Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder

NCT03558919 is registered in ClinicalTrials.gov with Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh as lead sponsor.

NCT NCT03558919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03558919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder
Lead sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2017
Completion date
December 30, 2017
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder